Parexel, a clinical research organization (CROs) providing the full range of Phase I to IV clinical development services, announced the appointment of Keri Mattox to the newly created role of Chief Business Officer.
In this role, Mattox will lead the company’s business operations and growth strategy. She brings to Parexel more than 25 years of healthcare experience across corporate strategy and development, investor relations, communications and environmental, social and governance (ESG) programs.
Prior to joining Parexel, Mattox served as Chief Communications and Administration Officer at Zimmer Biomet. Earlier in her professional career, she was Global Lead of Integrated Corporate Communications at W2O Group (now Real Chemistry) and served as Vice President, Corporate & Investor Relations at Fortune 20 company AmerisourceBergen (now Cencora). Ms. Mattox also held executive leadership positions at Endo International and Auxilium Pharmaceuticals.
As part of the company’s senior leadership team, she will help drive the next phase of Parexel’s growth and will report to Chief Executive Officer Peyton Howell.
“I’m extremely excited to join Parexel at such a pivotal time in the company’s evolution and growth. Parexel has demonstrated operational excellence and a truly Patients-First approach, providing the world’s leading biopharmaceutical companies with integrated solutions and expertise that accelerate new therapies to market. I look forward to working with the team as we continue to expand our global footprint, drive above-market growth in key segments and achieve new innovation milestones — all with the goal of delivering better trials for patients, faster,” said Mattox.
“We’re pleased to welcome Keri to Parexel during an important time in our strategic transformation. Her extensive expertise, proven leadership and strong partnerships in the pharmaceutical and medical technology industries will be extremely valuable as we position Parexel for the next phase of our growth. I know she will be a tremendous asset to the company and our leadership team,” said Peyton Howell, Chief Executive Officer.
